Hospital readmissions and measures of quality.


tent of cytoreduction, differences in primary and secondary outcomes between BRCA1and BRCA2-mutated cases remained. Larger cohorts will be required for further validation. With regard to chemotherapy in the setting of recurrent disease, the likelihood of response depends, in part, on the time to recurrence. Such analyses were beyond the scope of the current… (More)
DOI: 10.1001/jama.2012.11


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics